Home › T-Cell Lymphoma › Indiana
T-Cell Lymphoma clinical trials in Indiana
3 studies for T-Cell Lymphoma are looking for participants at sites in Indiana.
Cities in Indiana
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT06724237CD4CAR for CD4+ Leukemia and Lymphoma
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Riley Hospital for Children, Indianapolis
RecruitingPhase 1
Ages 12 and older · All sexes · Updated Jun 24, 2026 · NCT03829540Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Riley Hospital for Children, Indianapolis
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.